Portage Biotech
PRTG
#8194
Rank
$9.47 M
Marketcap
British Virgin Islands
Country
$0.48
Share price
91.56%
Change (1 day)
-86.92%
Change (1 year)
Categories
Revenue for Portage Biotech (PRTG)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Portage Biotech from 2008 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2023 (TTM)  | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | $0.09 M | |
| 2011 | N/A | -100% |
| 2010 | $0.63 M | -96308.93% |
| 2009 | -$0.01 M | -100.87% |
| 2008 | $0.07 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | $0.14 B | N/A | 🇺🇸 USA |